Cytophage Technologies Ltd.
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and … Read more
Market Cap & Net Worth: Cytophage Technologies Ltd. (CYTO)
Cytophage Technologies Ltd. (V:CYTO) has a market capitalization of $3.06 Million (CA$4.40 Million) as of March 19, 2026. Listed on the V stock exchange, this Canada-based company holds position #33147 globally and #293 in its home market, demonstrating a -40.91% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cytophage Technologies Ltd.'s stock price CA$0.07 by its total outstanding shares 67685221 (67.69 Million).
Cytophage Technologies Ltd. Market Cap History: 2024 to 2026
Cytophage Technologies Ltd.'s market capitalization history from 2024 to 2026. Data shows change from $13.90 Million to $2.83 Million (-66.07% CAGR).
Cytophage Technologies Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cytophage Technologies Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CYTO by Market Capitalization
Companies near Cytophage Technologies Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Cytophage Technologies Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Cytophage Technologies Ltd. Historical Marketcap From 2024 to 2026
Between 2024 and today, Cytophage Technologies Ltd.'s market cap moved from $13.90 Million to $ 2.83 Million, with a yearly change of -66.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$2.83 Million | -60.00% |
| 2025 | CA$7.07 Million | -49.15% |
| 2024 | CA$13.90 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cytophage Technologies Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.06 Million USD |
| MoneyControl | $3.06 Million USD |
| MarketWatch | $3.06 Million USD |
| marketcap.company | $3.06 Million USD |
| Reuters | $3.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.